Urea cycle and ammonia-scavenging pathways

The urea cycle and ammonia-scavenging pathways are a critical metabolic system primarily located in the liver that facilitates the detoxification of ammonia, a neurotoxic byproduct of protein metabolism, by converting it into water-soluble urea for renal excretion (StatPearls, 2023). This pathway involves five primary enzymes—carbamoyl phosphate synthetase 1 (CPS1), ornithine transcarbamylase (OTC), argininosuccinate synthetase 1 (ASS1), argininosuccinate lyase (ASL), and arginase 1 (ARG1)—along with the essential allosteric activator N-acetylglutamate synthase (NAGS) (NIH, 2024). Genetic deficiencies in any of these enzymes result in urea cycle disorders (UCDs), leading to hyperammonemia, which can cause irreversible neurological damage, coma, or death if untreated (Häberle et al., 2019). Pharmacological intervention typically involves nitrogen-scavenging agents like sodium phenylbutyrate and sodium benzoate, which create alternative metabolic routes for nitrogen excretion by conjugating with glutamine and glycine, respectively (PubChem). Other therapeutic approaches include the use of carglumic acid as a functional analogue for NAGS deficiency and enzyme replacement therapies like pegzilarginase for arginase deficiency (FDA, 2023). Beyond genetic disorders, these pathways are therapeutic targets in managing hepatic encephalopathy associated with chronic liver disease (Journal of Hepatology, 2022). This enzymatic network is essential for maintaining nitrogen balance and preventing systemic toxicity from endogenous waste products.

Other names

Urea cycleOrnithine cycleAmmonia detoxification pathwayNitrogen metabolism pathwayUCD enzymatic pathwayKrebs-Henseleit cycle

Drugs targeting these pathways function by providing alternative routes for nitrogen excretion through amino acid conjugation (nitrogen scavenging), providing allosteric activation of deficient enzymes, replacing missing enzymes, or supplying metabolic intermediates to maintain pathway flux.